 Cassidy Delaney
Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 6 | 2020 | 1597 | 1.810 |
Why?
| | Receptor, Serotonin, 5-HT2A | 3 | 2020 | 13 | 1.580 |
Why?
| | Vascular Remodeling | 2 | 2018 | 110 | 1.300 |
Why?
| | Bleomycin | 4 | 2020 | 193 | 1.160 |
Why?
| | Pulmonary Artery | 3 | 2015 | 1073 | 1.070 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2018 | 271 | 1.060 |
Why?
| | Serotonin | 3 | 2020 | 351 | 1.060 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2018 | 112 | 0.910 |
Why?
| | Platelet Activation | 1 | 2020 | 48 | 0.900 |
Why?
| | Protective Agents | 1 | 2018 | 40 | 0.770 |
Why?
| | Superoxide Dismutase | 2 | 2019 | 347 | 0.740 |
Why?
| | Nitric Oxide | 2 | 2019 | 847 | 0.710 |
Why?
| | Evidence-Based Medicine | 1 | 2019 | 711 | 0.620 |
Why?
| | Lung | 5 | 2020 | 3314 | 0.620 |
Why?
| | Serotonin Uptake Inhibitors | 2 | 2013 | 97 | 0.590 |
Why?
| | Pulmonary Alveoli | 2 | 2020 | 367 | 0.580 |
Why?
| | Endothelial Cells | 2 | 2015 | 569 | 0.550 |
Why?
| | Intestinal Obstruction | 1 | 2012 | 31 | 0.520 |
Why?
| | Animals, Newborn | 4 | 2020 | 912 | 0.520 |
Why?
| | Hernia, Diaphragmatic | 1 | 2012 | 71 | 0.510 |
Why?
| | Fetus | 2 | 2013 | 598 | 0.490 |
Why?
| | Ketanserin | 3 | 2018 | 13 | 0.470 |
Why?
| | Serotonin 5-HT2 Receptor Antagonists | 2 | 2013 | 10 | 0.270 |
Why?
| | Sertraline | 2 | 2013 | 18 | 0.270 |
Why?
| | Vascular Resistance | 2 | 2013 | 363 | 0.240 |
Why?
| | Antibiotics, Antineoplastic | 2 | 2019 | 128 | 0.240 |
Why?
| | Aurothioglucose | 1 | 2020 | 6 | 0.230 |
Why?
| | Platelet Factor 4 | 1 | 2020 | 12 | 0.230 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 4890 | 0.230 |
Why?
| | Air | 1 | 2020 | 54 | 0.220 |
Why?
| | Extracellular Fluid | 1 | 2019 | 33 | 0.220 |
Why?
| | Hyperoxia | 1 | 2020 | 79 | 0.210 |
Why?
| | Animals | 7 | 2020 | 33663 | 0.200 |
Why?
| | Neovascularization, Physiologic | 1 | 2020 | 174 | 0.200 |
Why?
| | Serotonin Antagonists | 1 | 2018 | 27 | 0.200 |
Why?
| | Administration, Inhalation | 1 | 2019 | 629 | 0.190 |
Why?
| | Blood Platelets | 1 | 2020 | 295 | 0.180 |
Why?
| | Extracellular Matrix | 1 | 2019 | 320 | 0.180 |
Why?
| | Infant, Newborn | 2 | 2019 | 4572 | 0.180 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3684 | 0.170 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 339 | 0.170 |
Why?
| | Ventricular Pressure | 1 | 2015 | 38 | 0.170 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 88 | 0.160 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2015 | 199 | 0.150 |
Why?
| | Ventricular Function, Right | 1 | 2015 | 196 | 0.140 |
Why?
| | Sheep, Domestic | 1 | 2013 | 31 | 0.140 |
Why?
| | Tryptophan Hydroxylase | 1 | 2013 | 48 | 0.140 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2015 | 183 | 0.140 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 142 | 0.130 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2015 | 482 | 0.130 |
Why?
| | Apoptosis | 2 | 2020 | 2524 | 0.130 |
Why?
| | Hysterotomy | 1 | 2011 | 10 | 0.130 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2011 | 30 | 0.130 |
Why?
| | Oxadiazoles | 1 | 2011 | 30 | 0.130 |
Why?
| | Receptors, Serotonin | 1 | 2011 | 43 | 0.130 |
Why?
| | Fluoxetine | 1 | 2011 | 44 | 0.120 |
Why?
| | Fatal Outcome | 1 | 2012 | 305 | 0.120 |
Why?
| | rho-Associated Kinases | 1 | 2011 | 73 | 0.120 |
Why?
| | Phosphorylation | 1 | 2015 | 1758 | 0.120 |
Why?
| | Diseases in Twins | 1 | 2012 | 250 | 0.110 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2012 | 140 | 0.110 |
Why?
| | Death, Sudden, Cardiac | 1 | 2012 | 205 | 0.110 |
Why?
| | Sheep | 1 | 2011 | 716 | 0.100 |
Why?
| | Cells, Cultured | 2 | 2019 | 4283 | 0.100 |
Why?
| | Respiratory Insufficiency | 1 | 2012 | 245 | 0.100 |
Why?
| | Piperazines | 1 | 2011 | 288 | 0.100 |
Why?
| | Indoles | 1 | 2011 | 337 | 0.100 |
Why?
| | Inflammation | 1 | 2019 | 2071 | 0.100 |
Why?
| | Oxidative Stress | 1 | 2015 | 1140 | 0.100 |
Why?
| | Mice, Knockout | 1 | 2015 | 2739 | 0.100 |
Why?
| | Phenotype | 1 | 2015 | 2751 | 0.090 |
Why?
| | Pyridines | 1 | 2011 | 454 | 0.090 |
Why?
| | Gene Expression | 1 | 2013 | 1503 | 0.090 |
Why?
| | Hemodynamics | 1 | 2011 | 1022 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2015 | 2244 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2011 | 2228 | 0.080 |
Why?
| | Signal Transduction | 2 | 2020 | 4768 | 0.080 |
Why?
| | Mice | 2 | 2019 | 14439 | 0.080 |
Why?
| | Humans | 4 | 2019 | 99981 | 0.060 |
Why?
| | Female | 3 | 2020 | 57853 | 0.060 |
Why?
| | Pregnancy | 1 | 2011 | 4561 | 0.060 |
Why?
| | Male | 2 | 2020 | 56936 | 0.060 |
Why?
| | Infant | 1 | 2012 | 7362 | 0.050 |
Why?
| | Glutathione | 1 | 2020 | 364 | 0.050 |
Why?
| | Fibrosis | 1 | 2019 | 341 | 0.050 |
Why?
| | Acute Disease | 1 | 2020 | 958 | 0.050 |
Why?
| | Transcriptome | 1 | 2020 | 436 | 0.040 |
Why?
| | Up-Regulation | 1 | 2020 | 962 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1471 | 0.030 |
Why?
| | DNA | 1 | 2020 | 1390 | 0.030 |
Why?
| | Adult | 1 | 2013 | 29332 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 1929 | 0.030 |
Why?
|
|
Delaney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|